Burning Rock Biotech Ltd (BNR) — Capital Reinvestment Ratio

Latest as of June 2020: 1.24x

Burning Rock Biotech Ltd (BNR) has a Capital Reinvestment Ratio of 1.24x as of June 2020, meaning it reinvests 1% of its operating cash flow ($61.12 Million) in capital expenditures ($75.57 Million). Check BNR tangible net assets ratio to evaluate the tangible quality of the company's equity base.

Capital Reinvestment Ratio

1.24x
Capex / Operating Cash Flow

Operating Cash Flow

$61.12 Million
USD

Capital Expenditures

$75.57 Million
USD

Data as of

Jun 2020
Most recent filing

Annual Capital Reinvestment Ratio for Burning Rock Biotech Ltd (None–None)

Year-by-year Capital Reinvestment Ratio for Burning Rock Biotech Ltd from None to None. See Burning Rock Biotech Ltd (BNR) free cash flow to measure how efficiently the company converts operating cash flow to free cash.

Year Reinvestment Ratio Operating CF (USD) Capital Expenditures YoY Change
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow